Drug · DIN 02303663
SANDOZ RISPERIDONE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since December 21, 2007; first marketed December 21, 2007.
- Drug Identification Number (DIN)
- 02303663
- Company (DIN owner)
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Risperidone N05AX08
- Class
- Human
- Record last updated
- June 16, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RISPERIDONE | 0.5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 21, 2007: NOC 9264Supplement to an Abbreviated New Drug Submission (SANDS) · New strengths
Other DINs named SANDOZ RISPERIDONE
- DIN 02279800 · Marketed
- DIN 02279819 · Marketed
- DIN 02279827 · Marketed
- DIN 02279835 · Marketed
- DIN 02303655 · Marketed
- DIN 02279495 · Cancelled Post Market
- DIN 02279509 · Cancelled Post Market
- DIN 02292807 · Cancelled Post Market